Companies
BMI Regional Review: Western Europe
July 2007 | Industry NewsThe combined pharmaceutical market of Western Europe - comprising Belgium, France, Germany, Italy, Netherlands, Switzerland and the United Kingdom - had a value of US$151.6bn in 2006.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
